In contrast, although cher was identified in the arrays as being upregulated in both tumor types and previous studies have shown that cher is partly required for the deregulation of the Hippo pathway in scrib- + RasACT tumors [23], more direct evidence for Hippo pathway deregulation amongst the JNK signature genes was lacking. This evidence concerns the gene MAPK8 and neoplasm.